| Trial ID: | L7198 |
| Source ID: | NCT01492153
|
| Associated Drug: |
Biphasic Human Insulin
|
| Title: |
NovoLet® Surveillance Study on Using Human Insulin System in Indonesia
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: biphasic human insulin|DRUG: isophane human insulin|DRUG: human soluble insulin
|
| Outcome Measures: |
Primary: Change in body weight | Secondary: Fasting blood glucose (FBG)|2 hours postprandial blood glucose (2-hr PPBG)|HbA1c (glycosylated haemoglobin)|Adverse events (AEs) including hypoglycaemic episodes
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
1981
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2003-02-11
|
| Completion Date: |
2006-09-05
|
| Results First Posted: |
|
| Last Update Posted: |
2017-02-28
|
| Locations: |
Novo Nordisk Investigational Site, Jakarta, 12520, Indonesia
|
| URL: |
https://clinicaltrials.gov/show/NCT01492153
|
